U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Lifetime History-Informed Treatment for Chronic Pain, Mobility Impairment, or Organ Systems Dysfunction: A Review of Clinical Effectiveness and Guidelines

Lifetime History-Informed Treatment for Chronic Pain, Mobility Impairment, or Organ Systems Dysfunction: A Review of Clinical Effectiveness and Guidelines

CADTH Rapid Response Report: Summary with Critical Appraisal

, , and .

Context and Policy Issues

History taking has been shown to have an important role on the diagnosis and treatment of patients with chronic pain,14 mobility impairment, and organ system dysfunction such as musculoskeletal, gastrointestinal, cardiovascular, and hormonal systems.510 Lifetime history taking, as opposed to short-term history taking, has been shown to link current chronic pain and functional system dysfunction to their root causes in survivors of sexual assaults,11 motor vehicle collision,12 work-related injury13 and other traumatic events.14,15 The clinical benefit of treatment based on lifetime history taking needs to be proven to determine its importance.

This Rapid Response report aims to review the clinical and cost-effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction. Evidence-based guidelines on lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction will also be reviewed.

Research Question

  1. What is the clinical effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction in patients?
  2. What are the evidence-based guidelines regarding lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction?

Key Findings

There were no studies that met the pre-specified criteria regarding the clinical and cost-effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction. No evidence-based guidelines on the use of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction were found.

Methods

A limited literature search was conducted on key resources including Ovid Medline, PubMed (for non-Medline records), the Cochrane Library, University of York Centre for Reviews and Dissemination (CRD) databases, Canadian and major international health technology agencies, as well as a focused Internet search. A focused search for all study types of interest was conducted. For this search, main concepts appeared in the title or as major subject headings and methodological filters were applied to limit retrieval to health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, and guidelines. Where possible, retrieval was limited to the human population. The search was also limited to English language documents published between January 1, 2013 and October 15, 2018.

Rapid Response reports are organized so that the evidence for each research question is presented separately.

Selection Criteria and Methods

One reviewer screened citations and selected studies. In the first level of screening, titles and abstracts were reviewed and potentially relevant articles were retrieved and assessed for inclusion. The final selection of full-text articles was based on the inclusion criteria presented in Table 1.

Table 1. Selection Criteria.

Table 1

Selection Criteria.

Exclusion Criteria

Articles were excluded if they did not meet the selection criteria outlined in Table 1, they were duplicate publications, or were published prior to 2013.

Critical Appraisal of Individual Studies

Critical appraisal was not performed as no eligible studies were identified.

Summary of Evidence

Quantity of Research Available

A total of 429 citations were identified in the literature search. Following screening of titles and abstracts, 419 citations were excluded and ten potentially relevant reports from the electronic search were retrieved for full-text review. No potentially relevant publication was retrieved from the grey literature search. Of these potentially relevant articles, ten publications were excluded for various reasons, and no publications met the inclusion criteria and were included in this report. Appendix 1 presents the PRISMA flowchart of the study selection.

Summary of Findings

No relevant HTAs, SRs, MAs, RCTs, non-RCTs, cost studies, or evidence-based guidelines on the clinical effectiveness or cost-effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction were identified.

Conclusions and Implications for Decision or Policy Making

There were no studies that met the pre-specified criteria regarding the clinical and cost-effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction. No evidence-based guidelines on the use of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction were found.

Clinical and economic studies regarding the clinical and cost-effectiveness of lifetime history-informed treatment for chronic pain, mobility impairment, or organ systems dysfunction are needed. Evidence –based guidelines are needed to guide the use of lifetime history taking.

References

1.
Pestka EL, Craner J, Evans M, et al. Impact of family history of substance abuse on admission opioid dose, depressive symptoms, and pain catastrophizing in patients with chronic pain. Pain Manag Nurs. 2018;19(2):115–124. [PubMed: 29153294]
2.
Maas ET, Juch JN, Ostelo RW, et al. Systematic review of patient history and physical examination to diagnose chronic low back pain originating from the facet joints. Eur J Pain. 2017;21(3):403–414. [PubMed: 27723170]
3.
Grodahl LH, Fawcett L, Nazareth M, et al. Diagnostic utility of patient history and physical examination data to detect spondylolysis and spondylolisthesis in athletes with low back pain: a systematic review. Man Ther. 2016;24:7–17. [PubMed: 27317501]
4.
Muller M, Kamping S, Benrath J, et al. Treatment history and placebo responses to experimental and clinical pain in chronic pain patients. Eur J Pain. 2016;20(9):1530–1541. [PubMed: 27062187]
5.
Davis DL, Mulligan ME, Moszkowicz A, Resnik CS. Clinical history provided by referring clinicians and patients for musculoskeletal MRI. J Am Coll Radiol. 2017;14(9):1215–1218. [PMC free article: PMC6759058] [PubMed: 28465025]
6.
Katz JN, Smith SR, Yang HY, et al. Value of history, physical examination, and radiographic findings in the diagnosis of symptomatic meniscal tear among middle-aged subjects with knee pain. Arthritis Care Res (Hoboken). 2017;69(4):484–490. [PMC free article: PMC5219865] [PubMed: 27390312]
7.
Jain A, Mehta N, Secko M, et al. History, physical examination, laboratory testing, and emergency department ultrasonography for the diagnosis of acute cholecystitis. Acad Emerg Med. 2017;24(3):281–297. [PubMed: 27862628]
8.
Iliceto A, Berndt SL, Greenslade JH, et al. Agreement between patient-reported and cardiology-adjudicated medical history in patients with possible ischemic chest pain: an observational study. Crit Pathw Cardiol. 2016;15(3):121–125. [PubMed: 27465009]
9.
Wanigatunga AA, Sourdet SS, LaMonte MJ, et al. Physical impairment and body weight history in postmenopausal women: the Women’s Health Initiative. Public Health Nutr. 2016;19(17):3169–3177. [PMC free article: PMC5135627] [PubMed: 27269298]
10.
Raynor MB, Kuhn JE. Utility of features of the patient’s history in the diagnosis of atraumatic shoulder pain: a systematic review. J Shoulder Elbow Surg. 2016;25(4):688–694. [PubMed: 26711472]
11.
Spiegel DR, Shaukat AM, Mccroskey AL, et al. Conceptualizing a subtype of patients with chronic pain: the necessity of obtaining a history of sexual abuse. Int J Methods Psychiatr Res Med. 2016;51(1):84–103. [PubMed: 26681238]
12.
Nolet PS, Kristman VL, Cote P, Carroll LJ, Cassidy JD. The association between a lifetime history of low back injury in a motor vehicle collision and future low back pain: a population-based cohort study. Eur Spine J. 2018;27(1):136–144. [PubMed: 28391385]
13.
Nolet PS, Kristman VL, Cote P, Carroll LJ, Hincapie CA, David Cassidy J. The association between a lifetime history of work-related low back injury and future low back pain: a population-based cohort study. Eur Spine J. 2016;25(4):1242–1250. [PubMed: 26208942]
14.
Scott KM, Koenen KC, Aguilar-Gaxiola S, et al. Associations between lifetime traumatic events and subsequent chronic physical conditions: a cross-national, cross-sectional study. PLoS One. 2013;8(11):e80573. [PMC free article: PMC3864645] [PubMed: 24348911]
15.
Whiteneck GG, Cuthbert JP, Corrigan JD, Bogner JA. Prevalence of self-reported lifetime history of traumatic brain injury and associated disability: a statewide population-based survey. J Head Trauma Rehabil. 2016;31(1):E55–62. [PubMed: 25931187]

Appendix 1. Selection of Included Studies

Image app1f1

About the Series

CADTH Rapid Response Report: Summary with Critical Appraisal
ISSN: 1922-8147

Version: 1.0

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.

Suggested citation:

Lifetime History-Informed Treatment for Chronic Pain, Mobility Impairment, or Organ Systems Dysfunction: A Review of Clinical Effectiveness and Guidelines. Ottawa: CADTH; 2018 July. (CADTH rapid response report: summary with critical appraisal).

Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services.

While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up-to-date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. The views and opinions of third parties published in this document do not necessarily state or reflect those of CADTH.

CADTH is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials.

This document may contain links to third-party websites. CADTH does not have control over the content of such sites. Use of third-party sites is governed by the third-party website owners’ own terms and conditions set out for such sites. CADTH does not make any guarantee with respect to any information contained on such third-party sites and CADTH is not responsible for any injury, loss, or damage suffered as a result of using such third-party sites. CADTH has no responsibility for the collection, use, and disclosure of personal information by third-party sites.

Subject to the aforementioned limitations, the views expressed herein are those of CADTH and do not necessarily represent the views of Canada’s federal, provincial, or territorial governments or any third party supplier of information.

This document is prepared and intended for use in the context of the Canadian health care system. The use of this document outside of Canada is done so at the user’s own risk.

This disclaimer and any questions or matters of any nature arising from or relating to the content or use (or misuse) of this document will be governed by and interpreted in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein, and all proceedings shall be subject to the exclusive jurisdiction of the courts of the Province of Ontario, Canada.

Copyright © 2018 Canadian Agency for Drugs and Technologies in Health.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK538917PMID: 30892855

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (399K)

Other titles in this collection

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...